Walmart Settles Opioid Case for $50 Million, Avoiding Major Legal Penalty
Walmart has settled a long-running federal opioid case with the U.S. government by paying $50 million to resolve claims that its pharmacies filled thousands of invalid prescriptions. The settlement ends a lawsuit dating back to December 2020 and avoids potential penalties in the billions, which had been possible under the Controlled Substances Act. The legal threat was significantly reduced after Judge Colm Connolly dismissed key parts of the government's case in March 2024, including claims related to unreported suspicious orders. The remaining allegations focused on Walmart pharmacists filling prescriptions that were known to be invalid. Despite admitting no wrongdoing, Walmart’s stock rose following the settlement announcement. The $50 million fine is considered immaterial for a company with significant financial resources—Walmart reported $11.79 billion in net income over six months ending July 31. The resolution removes substantial legal uncertainty and reduces potential future liabilities.
Tickers: $WMT
Topics: legal opioids pharmaceuticals